NCT05805631 2026-03-24
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
Taipei Veterans General Hospital, Taiwan
Phase 2 Recruiting
Clinical Trials
7 trialsNCT07100600 2025-08-11
Trastuzumab Rezetecan Combined With Radiotherapy Versus Trastuzumab Rezetecan in the Treatment of HER2-positive Advanced Breast Cancer With Brain Metastases
Henan Cancer Hospital
Phase 2 Recruiting
NCT06971406 2025-05-14
FLAME-1
Henan Cancer Hospital
Phase 2 Not yet recruiting
NCT06441045 2024-06-04
Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06051240 2024-04-12
LiBRA
Region Stockholm
Phase 2 Recruiting
NCT02029573 2017-08-18
ART
King Fahad Medical City
Phase 2 Completed
NCT00484978 2007-06-12
Stereotactic Radiosurgery to the Resection Cavity Following Surgical Removal of Brain Metastasis
Tel-Aviv Sourasky Medical Center
Phase 2 Unknown